These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 34983996)
1. Brolucizumab: Evaluation of Compassionate Use of a Complex Anti-VEGF Therapy. Murray JE; Gold AS; Latiff A; Murray TG Clin Ophthalmol; 2021; 15():4731-4738. PubMed ID: 34983996 [TBL] [Abstract][Full Text] [Related]
2. Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration. Enríquez AB; Baumal CR; Crane AM; Witkin AJ; Lally DR; Liang MC; Enríquez JR; Eichenbaum DA JAMA Ophthalmol; 2021 Apr; 139(4):441-448. PubMed ID: 33630045 [TBL] [Abstract][Full Text] [Related]
3. First Year Real Life Experience With Intravitreal Brolucizumab for Treatment of Refractory Neovascular Age-Related Macular Degeneration. Abdin AD; Aljundi W; El Jawhari K; Suffo S; Weinstein I; Seitz B Front Pharmacol; 2022; 13():860784. PubMed ID: 35721125 [No Abstract] [Full Text] [Related]
4. Short-term outcomes following treatment of recalcitrant cystoid macular edema secondary to radiation maculopathy using intravitreal brolucizumab. Corradetti G; Corvi F; Juhn A; Sadda SR Am J Ophthalmol Case Rep; 2020 Dec; 20():100981. PubMed ID: 33145457 [TBL] [Abstract][Full Text] [Related]
5. Retinal arterial occlusive vasculitis after multiple intravitreal brolucizumab injections for diabetic macular edema. Hirano T; Toriyama Y; Takahashi Y; Hoshiyama K; Murata T Am J Ophthalmol Case Rep; 2023 Mar; 29():101788. PubMed ID: 36632338 [TBL] [Abstract][Full Text] [Related]
6. Off-label intravitreal brolucizumab for recalcitrant diabetic macular edema: A real-world case series. Chakraborty D; Sheth JU; Boral S; Sinha TK Am J Ophthalmol Case Rep; 2021 Dec; 24():101197. PubMed ID: 34504981 [TBL] [Abstract][Full Text] [Related]
7. Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab. Baumal CR; Spaide RF; Vajzovic L; Freund KB; Walter SD; John V; Rich R; Chaudhry N; Lakhanpal RR; Oellers PR; Leveque TK; Rutledge BK; Chittum M; Bacci T; Enriquez AB; Sund NJ; Subong ENP; Albini TA Ophthalmology; 2020 Oct; 127(10):1345-1359. PubMed ID: 32344075 [TBL] [Abstract][Full Text] [Related]
8. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal brolucizumab as treatment of early onset radiation retinopathy secondary to plaque brachytherapy for choroidal melanoma. Villegas NC; Mishra K; Steinle N; Liu W; Beadle B; Mruthyunjaya P Am J Ophthalmol Case Rep; 2022 Sep; 27():101581. PubMed ID: 35599950 [TBL] [Abstract][Full Text] [Related]
10. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema. Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840 [TBL] [Abstract][Full Text] [Related]
11. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X; Li J; Hu X; Yu S; Pan J; Tang S Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [TBL] [Abstract][Full Text] [Related]
15. Case Series on Initial Responses to Intravitreal Brolucizumab in Patients with Recalcitrant Chronic Wet Age-Related Macular Degeneration. Avaylon J; Lee S; Gallemore RP Int Med Case Rep J; 2020; 13():145-152. PubMed ID: 32494207 [TBL] [Abstract][Full Text] [Related]
16. Advanced Coats' disease treated with intravitreal brolucizumab combined with laser photocoagulation. Patel NA; Berrocal AM; Murray TG; Villegas VM Am J Ophthalmol Case Rep; 2020 Sep; 19():100815. PubMed ID: 32671288 [TBL] [Abstract][Full Text] [Related]
17. Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration. Haug SJ; Hien DL; Uludag G; Ngoc TTT; Lajevardi S; Halim MS; Sepah YJ; Do DV; Khanani AM Am J Ophthalmol Case Rep; 2020 Jun; 18():100680. PubMed ID: 32258827 [TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone injection for diabetic macular edema: a clinical and fluorescein angiographic case series. Bakri SJ; Beer PM Can J Ophthalmol; 2004 Dec; 39(7):755-60. PubMed ID: 15696765 [TBL] [Abstract][Full Text] [Related]
19. The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema. Desatnik H; Habot-Wilner Z; Alhalel A; Moroz I; Glovinsky J; Moisseiev J Isr Med Assoc J; 2006 Jun; 8(6):383-7. PubMed ID: 16833165 [TBL] [Abstract][Full Text] [Related]
20. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema. Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]